Phase 3 Psoriatic Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Juvenile Psoriatic Arthritis (JPsA).
- People who have at least three joints affected by arthritis.
- People who have tried at least one medication for JPsA for three months or more, but the medication did not work well enough or caused problems.
Who may not be able to join:
- People who were first diagnosed with JPsA before the age of 5.
- People who have been diagnosed with other forms of Juvenile Idiopathic Arthritis (JIA) that are not JPsA.
- People who have a history of chronic eye inflammation (uveitis), or who were diagnosed with uveitis within the last three months.
- There are additional criteria set out in the trial protocol that may affect eligibility (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to first flare during the withdrawal period
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.